BioScrip (BIOS) Misses Q2 EPS by 14c, Revs Modestly Lower; Reiterates Outlook

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/18/2026

1. SPY
2. EYPT
3. NVDA
4. ARGX
5. TSLA
6. USO
7. AWK
8. HD
9. GNK
10. MU

Go back to BioScrip (BIOS) Misses Q2 EPS by 14c, Revs Modestly Lower; Reiterates Outlook

BioScrip (BIOS) PT Raised to $4 at Jefferies; Reiterates Buy

August 9, 2017 8:35 AM EDT

Jefferies raised its price target on BioScrip (NASDAQ: BIOS) to $4.00 (from $3.00) while maintaining a Buy rating following 2Q. EBITDA of $10MM was ahead of consensus and nearly doubled on a sequential basis, while Core revenue was up 2% Q/Q and grew to 73.1% of total... More